Colon Cancer Survival Rates With the New American Joint Committee on Cancer Sixth Edition Staging

阶段(地层学) 癌症 AJCC分段系统 医学 癌症分期 监测、流行病学和最终结果 流行病学 腺癌 肿瘤科 结直肠癌 癌症登记处 内科学 外科 登台系统 古生物学 生物
作者
J. B. O'Connell,Melinda A. Maggard,Clifford Y. Ko
出处
期刊:Journal of the National Cancer Institute [Oxford University Press]
卷期号:96 (19): 1420-1425 被引量:1584
标识
DOI:10.1093/jnci/djh275
摘要

Background: The recently revised American Joint Committee on Cancer (AJCC) sixth edition cancer staging system increased the stratification within colon cancer stages II and III defined by the AJCC fifth edition system. Using nationally representative Surveillance, Epidemiology, and End Results (SEER) data, we compared survival rates associated with colon cancer stages defined according to both AJCC systems. Methods: Using SEER data (from January 1, 1991, through December 31, 2000), we identified 119 363 patients with colon adenocarcinoma and included all patients in two analyses by stages defined by AJCC fifth and sixth edition systems. Tumors were stratified by SEER’s “extent of disease” and “number of positive [lymph] nodes” coding schemes. Kaplan–Meier analyses were used to compare overall and stage-specific 5-year survival. All statistical tests were two-sided. Results: Overall 5-year survival was 65.2%. According to stages defined by the AJCC fifth edition system, 5-year stage-specific survivals were 93.2% for stage I, 82.5% for stage II, 59.5% for stage III, and 8.1% for stage IV. According to stages defined by the AJCC sixth edition system, 5-year stage-specific survivals were 93.2% for stage I, 84.7% for stage IIa, 72.2% for stage IIb, 83.4% for stage IIIa, 64.1% for stage IIIb, 44.3% for stage IIIc, and 8.1% for stage IV. Under the sixth edition system, 5-year survival was statistically significantly better for patients with stage IIIa colon cancer (83.4%) than for patients with stage IIb disease (72.2%) (P<.001). Conclusions: The AJCC sixth edition system for colon cancer stratifies survival more distinctly than the fifth edition system by providing more substages. The association of stage IIIa colon cancer with statistically significantly better survival than stage IIb in the new system may reflect current clinical practice, in which stage III patients receive chemotherapy but stage II patients generally do not.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
Warming发布了新的文献求助10
刚刚
研友_LmAvmL完成签到,获得积分20
刚刚
今后应助欣慰元灵采纳,获得10
1秒前
威尔沐沐完成签到,获得积分10
1秒前
1秒前
酥酥完成签到 ,获得积分20
1秒前
syh发布了新的文献求助10
1秒前
XIONG发布了新的文献求助20
1秒前
gbh完成签到,获得积分10
2秒前
墨琼琼发布了新的文献求助10
2秒前
2秒前
柒辞发布了新的文献求助10
2秒前
congcong发布了新的文献求助10
2秒前
2秒前
美好斓发布了新的文献求助10
3秒前
顾矜应助rainsy采纳,获得10
3秒前
3秒前
不死鸟发布了新的文献求助10
3秒前
遇见完成签到,获得积分10
4秒前
慕青应助干净的夜蓉采纳,获得10
4秒前
所所应助下北沢采纳,获得10
4秒前
yifly2025发布了新的文献求助10
4秒前
M1212发布了新的文献求助10
4秒前
adi完成签到,获得积分10
5秒前
hy应助以恒之心采纳,获得10
5秒前
jinyu发布了新的文献求助10
5秒前
Yyyyyyyyy发布了新的文献求助10
5秒前
xy发布了新的文献求助10
5秒前
6秒前
研友_LmAvmL发布了新的文献求助10
6秒前
王运静完成签到,获得积分10
6秒前
7秒前
2220190143完成签到,获得积分10
8秒前
8秒前
zeyula发布了新的文献求助10
8秒前
脆脆鲨发布了新的文献求助10
8秒前
AoAoo发布了新的文献求助10
8秒前
8秒前
MYSHOW发布了新的文献求助10
9秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
PowerCascade: A Synthetic Dataset for Cascading Failure Analysis in Power Systems 2000
Picture this! Including first nations fiction picture books in school library collections 1500
Signals, Systems, and Signal Processing 610
Unlocking Chemical Thinking: Reimagining Chemistry Teaching and Learning 555
CLSI M100 Performance Standards for Antimicrobial Susceptibility Testing 36th edition 400
How to Design and Conduct an Experiment and Write a Lab Report: Your Complete Guide to the Scientific Method (Step-by-Step Study Skills) 333
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 物理 内科学 复合材料 催化作用 物理化学 光电子学 电极 细胞生物学 基因 无机化学
热门帖子
关注 科研通微信公众号,转发送积分 6364123
求助须知:如何正确求助?哪些是违规求助? 8178111
关于积分的说明 17236417
捐赠科研通 5419184
什么是DOI,文献DOI怎么找? 2867528
邀请新用户注册赠送积分活动 1844530
关于科研通互助平台的介绍 1692158